HealthEquity (HQY) Projected to Post Earnings on Tuesday

HealthEquity (NASDAQ:HQY) is projected to release its earnings data after the market closes on Tuesday, March 18th. Analysts expect HealthEquity to post earnings of $0.71 per share and revenue of $306.12 million for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.

HealthEquity Trading Up 3.7 %

Shares of HQY stock opened at $97.41 on Friday. The stock has a market cap of $8.44 billion, a price-to-earnings ratio of 89.37, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. The firm’s 50 day moving average price is $105.68 and its two-hundred day moving average price is $95.21. HealthEquity has a fifty-two week low of $65.01 and a fifty-two week high of $115.59. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51.

Insider Buying and Selling

In related news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now owns 78,219 shares of the company’s stock, valued at $8,704,992.51. This represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 2.20% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the stock. JMP Securities lifted their price objective on shares of HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research note on Tuesday, December 10th. Wells Fargo & Company lifted their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research note on Wednesday, February 26th. Mizuho began coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price target for the company. Raymond James lifted their price target on shares of HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Tuesday, February 25th. Finally, Barrington Research restated an “outperform” rating and issued a $112.00 price target on shares of HealthEquity in a research note on Friday. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat.com, HealthEquity has an average rating of “Moderate Buy” and a consensus target price of $112.92.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.